The pricing of prescription drugs is often the subject of debate. Many forget that pharmaceuticals and drug development form ...

Gambling culture is enveloping American sports, politics, media and trading, bringing betting out of the shadows and into the ...

Kevin Warsh understands the Fed’s mandate, respects its independence, and is willing to question comfortable assumptions when the evidence demands it.

If Trump were “totally focused on ... really bad criminals,” the U.S. would be having a very different kind of conversation. Reality, however, is stubborn.

Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs po ...

Like something from a galaxy far, far away, robots are getting closer to their big takeover.

The latest government shutdown ended last week, after a mere four days, but that was apparently enough to prevent the Bureau of Labor Statistics from releasing the January employment report. It will b ...

The first phase of the AI surge rewarded scale, speed, and story. The next phase will reward durability, profitability, and real economic advantage. My colleague Louis Navellier breaks down why recent ...

Most of what passes for urgent news has zero shelf life. Even if you read it a week later, you’ll see how little of it actually mattered.

The national debt will continue to soar. Bank on it. See Holman Jenkins’s column from last week for evidence. He wrote in the ...

It’s bonus season on Wall Street, and a record-setting 2025 is yielding bigger paychecks than ever for America’s investment ...

Bitcoin briefly falling below $60,000 last week has been treated as another episode of crypto volatility — familiar, dramatic, and easily dismissed as noise. That reaction misses what is actuall ...